在帕金森病中,血清IGF-1水平与非运动症状之间存在关联
Lihua Gu1, Pengcheng Zhang2, Wenchao Zuo1
1Department of Neurology, Tianjin Huanhu Hospital, No. 6 Jizhao Road, Tianjin, 300222, China.
概括
血清胰岛素样生长因子1 (IGF-1) 水平在帕金森病 (PD) 患者和对照人群之间没有差异. 然而,IGF-1与PD患者的非运动症状相关,包括认知功能和疲劳.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 临床神经学 临床神经学
背景情况:
- 新出现的证据表明,胰岛素样生长因子1 (IGF-1) 在帕金森病 (PD) 发病过程中与胰岛素相似.
- 异常IGF-1水平在PD非运动症状 (NMS) 中的特定作用需要进一步调查.
研究的目的:
- 在PD患者和健康对照 (HCs) 中量化血清IGF-1水平.
- 调查血清IGF-1水平与PD中NMS的存在和严重程度之间的关联.
主要方法:
- 血清IGF-1水平测量了129名PD患者 (74名早期,55名中期) 和130名HC患者.
- 使用线性回归分析来评估IGF-1水平与NMS之间的相关性,包括认知功能和疲劳.
主要成果:
- 在PD患者和HC患者之间,或在PD早期和中度阶段之间,没有观察到血清IGF-1水平的显著差异.
- 血清IGF-1水平与非运动症状量表 (NMSS) 评分,一般认知功能,信息处理速度和PD患者的执行功能有显著的关联.
- 较低的血清IGF-1水平与PD患者疲劳增加特别相关.
结论:
- 血清IGF-1水平可能与帕金森病的特定非运动症状有关.
- 需要进一步的纵向研究来探索血清生物标志物的潜力,如IGF-1,用于早期检测PD中的NMS.
更多相关视频
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.7K
08:33Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
8.2K
相关概念视频
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
01:15Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486
01:24Parkinson's Disease: Treatment
227
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
227